China Dominating Global Tetraspecific Antibody Clinical Trials Development Landscape Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China has emerged as a dominant force in the field of tetraspecific antibodies, leading the way in clinical trials and showing promising results in the...